Pantoprazole

Pantoprazole, the active ingredient in Pantoprazole, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): improves symptom control and promotes healing of erosive esophagitis. - Erosive peptic ulcer disease: accelerates healing of gastric and duodenal ulcers. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder. - Prevention of NSA‑induced gastric ulcers: reduces the risk of ulcer formation in patients requiring long‑term NSAID therapy. - Maintenance therapy for healed GERD: helps maintain remission after initial healing.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild, transient headache reported in clinical studies. - Diarrhoea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fracture risk: increased risk of hip, wrist or vertebral fractures with long‑term use. - Liver enzyme elevation: raised ALT/AST levels indicating hepatic stress.

When using Pantoprazole, consider the following precautions: - Renal impairment: adjust the ... - Long‑term use:  -   ... ... ... ... ... ... ... ... ...  \n-  ... ...  \\  """"  \